UBE Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

UBE şirketinin toplam hissedar öz sermayesi ¥439.7B ve toplam borcu ¥226.5B olup, bu da borç-öz sermaye oranını 51.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥807.5B ve ¥367.8B dir. UBE 'in FAVÖK'ü ¥22.3B faiz karşılama oranı -7.9 dur. Şirketin ¥33.1B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

51.5%

Borç/özkaynak oranı

JP¥226.53b

Borç

Faiz karşılama oranı	-7.9x
Nakit	JP¥33.11b
Eşitlik	JP¥439.68b
Toplam yükümlülükler	JP¥367.84b
Toplam varlıklar	JP¥807.51b

Son finansal sağlık güncellemeleri

Is UBE (TSE:4208) A Risky Investment?

May 01

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4208 'nin kısa vadeli varlıkları ( ¥296.7B ) kısa vadeli yükümlülüklerini ( ¥211.3B ) aşıyor.

Uzun Vadeli Yükümlülükler: 4208 şirketinin kısa vadeli varlıkları ( ¥296.7B ) uzun vadeli yükümlülüklerini ( ¥156.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4208 'nin net borç/öz sermaye oranı ( 44% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 4208 'nin borç/öz sermaye oranı son 5 yılda 54.2% seviyesinden 51.5% seviyesine düştü.

Borç Kapsamı: 4208 'nin borcu işletme nakit akışı ( 21% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 4208 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

UBE Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is UBE (TSE:4208) A Risky Investment?

UBE Corp American Depositary Receipts - Unsponsored to Be Deleted from Other OTC

Recent updates

UBE Corporation Revises Earnings Forecast for the First Half of Fiscal Year Ending March 31, 2025

Investors Could Be Concerned With UBE's (TSE:4208) Returns On Capital

iSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208).

Upcoming dividend of JP¥55.00 per share

First quarter 2025 earnings released: EPS: JP¥49.49 (vs JP¥37.67 in 1Q 2024)

Investor sentiment deteriorates as stock falls 19%

Final dividend of JP¥55.00 announced

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased by 9.8% to JP¥3,092

Consensus EPS estimates increase by 14%

Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

UBE Corporation to Report First Half, 2025 Results on Nov 07, 2024

Now 21% overvalued after recent price rise

Is UBE (TSE:4208) A Risky Investment?

UBE Corporation, Annual General Meeting, Jun 26, 2024

Estimating The Fair Value Of UBE Corporation (TSE:4208)

Price target increased by 8.3% to JP¥2,817

Upcoming dividend of JP¥50.00 per share

Market Participants Recognise UBE Corporation's (TSE:4208) Earnings

UBE Corporation to Report Fiscal Year 2024 Results on May 13, 2024

UBE Corporation Announces Appointment of Hideo Tamada as Director, Effective April 1, 2024

Third quarter 2024 earnings released: EPS: JP¥113 (vs JP¥8.39 loss in 3Q 2023)

Second quarter 2024 earnings released: EPS: JP¥55.26 (vs JP¥62.67 loss in 2Q 2023)

Upcoming dividend of JP¥50.00 per share at 3.7% yield

Now 21% undervalued

First quarter 2024 earnings released: EPS: JP¥37.67 (vs JP¥59.25 in 1Q 2023)

Price target increased by 13% to JP¥2,537

UBE Corporation Announces Dividend for the Year Ended March 31, 2023

Full year 2023 earnings released: JP¥72.25 loss per share (vs JP¥249 profit in FY 2022)

Consensus EPS estimates fall by 27%

Upcoming dividend of JP¥45.00 per share at 4.7% yield

Consensus EPS estimates fall by 15%

Consensus EPS estimates fall by 161%

Price target decreased by 7.3% to JP¥2,103

UBE Corporation Announces Organizational and Personnel Changes

Third quarter 2023 earnings released: JP¥8.39 loss per share (vs JP¥88.13 profit in 3Q 2022)

UBE Corporation to Report Q4, 2023 Results on May 12, 2023

Price target decreased to JP¥2,187

Less than half of directors are independent

Consensus forecasts updated

UBE Corporation Announces Resignation of Tetsuro Higashi, Outside Director, Effective January 4, 2023

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 51%

Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)

Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)

UBE Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

UBE Corporation Revises Earnings Guidance for the First Half Ended September 30, 2022 and Full Year Ending March 31, 2023

Santen Inc. and UBE Corporation Receives FDA Approval for OMLONTI(R) (Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Upcoming dividend of JP¥50.00 per share

Consensus forecasts updated

UBE Corporation Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥59.25 (vs JP¥47.31 in 1Q 2022)

UBE Corp American Depositary Receipts - Unsponsored to Be Deleted from Other OTC

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

Ube Corporation Provides Consolidated Earnings Guidance for the Period Ending September 2022 and March 31, 2023

Less than half of directors are independent

UBE Corporation to Report Q2, 2023 Results on Nov 04, 2022

UBE Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Ube Industries, Ltd. Announces Appointment of Makoto Koyama as Director, Effective April 1, 2022

Ube Industries, Ltd. Announces Abolishment of Construction Materials Company and Machinery Company and Eliminates Osaka Branch

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ube Industries, Ltd. Announces Dividend for Second Quarter Ended April 2021-March 2022; Provides Dividend Guidance for the Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥47.95 (vs JP¥15.85 in 2Q 2021)

Upcoming dividend of JP¥45.00 per share

Ube Industries, Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended September 2021 and Fiscal Year Ending March 31, 2022

First quarter 2022 earnings released: EPS JP¥47.31 (vs JP¥13.16 loss in 1Q 2021)

Full year 2021 earnings released: EPS JP¥227 (vs JP¥227 in FY 2020)

Ube Industries, Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended September 2021 and Fiscal Year Ending March 31, 2022

Ube Industries, Ltd. Revises Consolidated Earnings Guidance for the Full Year of the Fiscal Year Ended March 31, 2021

Consensus forecasts updated

Upcoming dividend of JP¥45.00 per share

Ube Industries, Ltd. to Report Fiscal Year 2021 Results on May 12, 2021